Agreed. It’s all about money. Though that’s what we all though the Samsung Bio announcement was all about. That Samsung was going to be a partner to fund a least one or more of the mabs into clinicals. Which is why it’s hard to understand why there’s still no Samsung update now just a few months shy of 2 years later. The $250 from SAGA should fund whatever they need for clinicals on the mabs and Clone 3, so hopefully this gets finalized asap and we get some IND (or EUA equivalent) filings finally.
when enzc starts injections in africa are they going to get paid for that.? it sounded like they were. there has been so much talk over this company the past 3 years, did enzc or africa even call this a trial or phase 3.? because i don't remember hearing that, all i remember hearing is when enzc starts treatments/injections in africa they will get paid. but i can't remember how much. anyone else read or hear something about this somewhere.?
OR ENZC may be in negotiations with other partners too, for as far as I know it's just a non-binding contract. At the very least, Enzolytics could be entertaining other partnerships that would benefit us more, in the event this SPAC deal falls thru. Another thing to consider, The SPAC deal gives ENZC more exposure to big investors. Who knows what will happen. But am confident CC is looking out for our Company & Shareholders best interest.
News 
Market Data 
Discover 
AI
